Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

关于海森生物

集研发、生产和商业推广,覆盖全产业链的海森生物医药有限公司(简称:海森生物)是一家创新型生物医药企业,成立于2020年,由亚洲一家专注于医疗健康行业的资产管理公司——康桥资本、合肥产投集团与合肥市肥东县共同投资组建。2023年4月,海森生物获得来自康桥资本和阿布扎比主权财富基金穆巴达拉投资公司等机构新一轮的融资,用于未来的收购和创新产品管线的业务发展。

秉承诚信、敏捷、创新和主人翁精神的核心价值观,海森生物致力于成为客户信赖、员工认可、社会尊重的健康行业*,携手政府相关机构、医疗卫生专业人士及业界合作伙伴,提供优质产品和解决方案,造福更多患者,共创社会健康价值。

公司首页:*

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (1 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3.15亿美元
  • Investor: 康桥资本,阿布扎比主权财富...

Recruitment Overview / Current Status

Manage
N/A
Growth Rate
Year-by-Year Hiring: 2025 has 2024 more positions than 25
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 海森生物医药有限公司 growing? 2025年38个,2024年13个,2023年13个,2022年46个,2021年17个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2023 — same as 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 海森生物医药有限公司 growing? 硕士 recruitment over the years: 2023年1个,2022年1个,2021年2个.

— What Are the Salaries Like? (14 records)

Manage
salary range: 10K - 50K, 85.7% of roles pay ¥10-20K
Note: salary statistics are based on 14 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 海森生物医药有限公司?85.7%的岗位拿10-20K,应届生 salary: ¥。Compared with the industry-10%,销售类平均工资¥13.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Related Industry Tags

Job Category

  • 销售类
    68.4% of total 68.4%
  • 医疗卫生/美容保健类
    47.4% of total 47.4%
  • 计算机/网络/技术类
    26.3% of total 26.3%
  • 客户服务类
    15.8% of total 15.8%

Education

  • 大专
    52.6% of total 52.6%
  • 本科
    47.4% of total 47.4%

Experience

  • 1-3年
    47.4% of total 47.4%
  • 5-10年
    21.1% of total 21.1%
  • 不限
    21.1% of total 21.1%
  • 应届生
    5.3% of total 5.3%
View Detailed Analysis

What does 海森生物医药有限公司 require? Who is 海森生物医药有限公司 hiring? recruitment: 销售类占比最多占68.4%,其次是医疗卫生/美容保健类占47.4%. What education can get in at ? 大专占比最多占52.6%,其次是本科占47.4%. Work experience required at ? 1-3年占比最多占47.4%,其次是5-10年占21.1%. Where are the job locations at ? 北京占比最多占21.1%,其次是上海占21.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 352,331.6667万(元)
Legal Representative: 刘文军
Date Established:
Credit Code: 91340122MA2W7Q5B0C
Registered Address: 安徽省合肥市肥东县店埠镇山水路99号

Partners & Suppliers

海森生物与武田中国达成战略合作,获得5款心血管药物在中国大陆的独家开发及商业化权利,武田为产品授权方。 Source
供应商 医药商业/分销渠道
国药控股作为海森生物医药产品的重点经销商,覆盖全国医药终端网络。 Source
合作客户 医药商业/分销渠道
海森生物与上海医药达成战略合作,上海医药成为海森生物产品的主要经销商,负责全国药品分销与市场推广。 Source
合作客户 医药商业/分销渠道

People who follow this company also follow

Competitors (Similar Companies)

金融 银行 商业银行 产融结合
物联网 IT基础设施 服务外包 人力资源外包
“致力于互联网改变物流”
“服务地方经济、服务中小企业、服务城乡居民”
“为工业级用户提供高效可靠的动力、视讯、自动化及节能应用解决方案”
通信工程 ISP 系统集成 数据中心
医药 CRO 制药/药业 心血管药
茶食品 植物饮料 凉茶 茶饮料
“手机上的视频制作、分享网站”
“致力于中小学生教育辅导和幼儿教育服务”
“让文化照明,添彩美丽中国。”
数据中心 创新服务 IDC CDN
信贷 金融 互联网金融 金融产品
行车记录仪 功放 DVD导航 车载DVD导航
科学研究 国际合作 教育资源共享 海外留学

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates